Advanced atypical lung carcinoid tumour successfully treated with carboplatin, etoposide and atezolizumab: A case report

• Main Authors: Fujita, A. (Author), Harada, T. (Author), Ijichi, K. (Author), Kawakami, S. (Author), Koike, A. (Author), Nakamura, S. (Author), Okamatsu, Y. (Author), Takahata, Y. (Author), Yamamoto, Y. (Author)
• Format: Article
• Language: English
• Published: John Wiley and Sons Inc 2022
• Subjects: atypical carcinoid tumour; case report; chemotherapy; immune checkpoint inhibitors; neuroendocrine tumour
• Online Access: View Fulltext in Publisher
• ISBN: 20513380 (ISSN)
• DOI: 10.1002/rcr2.951

Atypical carcinoid tumours are relatively rare among lung cancers. Surgery is regarded as standard treatment for localized cases, but there is little established evidence on treatment strategies for advanced cases. Moreover, the efficacy of immune checkpoint inhibitors for advanced carcinoid tumours is unclear. Here, we report a case of a patient with an atypical carcinoid tumour in whom successful disease control was achieved with the use of combined cytotoxic chemotherapy and immunotherapy. © 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.